《亞洲股市》日經及澳紐股市反覆逆軟 港股升幅曾擴至300點
美股反覆三連升,美國10月JOLTS職位空缺總數意外急彈至歷來第二高,輝瑞(PFE.US)與BioNTech(BNTX.US)指,初步實驗顯示,接種第三劑疫苗對Omicron變種新冠病毒中和抗體增加25倍,並稱他們正努力開發針對Omicron病毒疫苗,市場對新變種病毒憂慮繼續紓緩,旅遊相關股上揚,尤其是聯合航空(UAL.US)、皇家加勒比郵輪(RCL.US)、嘉年華郵輪(CCL.US)及挪威郵輪(NCLH.US)依次升逾4%-8%;費城半導體指數回吐0.6%,但獲大摩升價至200美元的蘋果(AAPL.US)據報要求供應商於11月至明年1月期間增加iPhone產量,股價續漲逾2%曾高見175.96美元屢創紀錄高,爲最強藍籌;特斯拉(TSLA.US)及Meta(FB.US)續漲1.6%-2.4%,Alphabet及奈飛續升約0.5%,支持納指及標指反覆續升0.6%及0.3%;過半道指成份股向好,其中安進、波音、IBM、運通、默克及迪士尼升1.1%-1.7%,但沃爾瑪、摩通、家得寶、Honeywell、英特爾及思科回吐1%-1.8%,拖累道指僅反覆續升35點或0.1%收35,754。然而,Omicron病毒於英國迅速擴散,首相約翰遜宣佈下週一收緊防疫限制措施,歐洲主要股市扭轉連日強勢全面回落,尤其是意股回吐1.4%,DAX及CAC回吐0.8%及0.7%。
美股期貨全面輕微回軟。亞太區股市普遍造好。美元兌日圓於亞洲靠穩報113.76,但日經連續兩天急升後,今早反覆回軟,最高見28,908,現報28,814,倒跌46點或近0.2%。新西蘭50指數繼昨天高收續漲2.1%後,今早回吐0.8%報12,768。澳洲200繼昨天漲近1.3%後,今天扭四連升,高低見7,409/7,377,現報7,399,回吐0.1%。
然而,無懼當地疫情嚴峻的南韓股市七連升,報3,016,升0.5%。臺灣加權指數連升第三天,報17,888,續升0.3%。新加坡海峽時數繼昨天回軟結束三連升後,今早回升0.6%報3,149。吉隆坡綜合指數回升0.1%報1,496。
內地11月通脹年率明顯升溫至2.3%,但不及市場預期升2.5%;11月PPI年升放緩至12.9%,高於市場預期升12.1%。滬指及深成繼昨天高收分別續升1.2%及回升1.8%結束兩連跌後,今早輕微高開0.1%及約1點,現報3,643及15,016,續升近0.2%及0.4%。
港股承過去兩連升勢,今早在藥明生物(02269.HK)、騰訊(00700.HK)、阿裏巴巴(09988.HK)、已兩連受捧李寧(02331.HK)及美團(03690.HK)高開1.5%-2.4%主導,恆指高開171點或0.7%報24,168,升幅曾擴至299點,高見24,296,現報24,256,續升259點或1.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.